Neogen Corporation Class Action Lawsuit Update for Investors

Neogen Corporation Investor Alert on Class Action Lawsuit
The Gross Law Firm has issued an important notice for all investors of Neogen Corporation (NASDAQ: NEOG). This announcement is particularly relevant for shareholders who purchased shares during the designated class period.
Who Should Pay Attention?
If you acquired shares of NEOG between the class period outlined in the allegations, your involvement is crucial. Contact the firm to learn about the opportunity to potentially be appointed as a lead plaintiff. However, remember that you don't have to be a lead plaintiff to partake in any recovery available.
Upcoming Deadline to Register
DEADLINE: September 16, 2025 is the key date for shareholders looking to register for this class action lawsuit. It's essential to not delay and ensure your information is submitted on time to safeguard your investment.
Allegations Against Neogen Corporation
The complaint filed alleges that Neogen Corporation’s management issued misleading statements to investors, indicating that the integration with the Food Safety Division of the 3M Company was advancing better than reality. Even during disclosures that highlighted operational inefficiencies from the integration, the management purportedly downplayed these issues while assuring investors of their commitment to addressing concerns promptly.
Steps for Interested Shareholders
Shareholders are encouraged to register as soon as possible. Upon registration, you will also gain access to a monitoring service, enabling you to receive updates and important information regarding the status of the case.
Why Choose Gross Law Firm?
The Gross Law Firm stands as a reputed name in the world of class action lawsuits. Their primary mission is to uphold the rights of investors who have faced losses due to fraud, deceit, or corporate misconduct. Their team is dedicated to ensuring companies are held accountable for their actions and that investors are fully informed of their rights.
How to Get in Touch
If you have any inquiries or would like to register your interest, please reach out to:
The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: dg@securitiesclasslaw.com
Phone: (646) 453-8903
Frequently Asked Questions
What is the class period for the Neogen Corporation lawsuit?
The class period for the Neogen Corporation lawsuit is from January 5, 2023, to June 3, 2025.
How can shareholders register for the class action?
Shareholders can register by contacting the Gross Law Firm to submit their information before the deadline of September 16, 2025.
What allegations are against Neogen Corporation?
The allegations center around misleading statements made by Neogen’s management regarding the integration with the 3M Company's Food Safety Division.
Who can be a lead plaintiff in the case?
Any shareholder who purchased shares of NEOG during the class period can potentially be appointed as a lead plaintiff.
Is there a cost to participate in the class action?
No, there is no cost or obligation for shareholders to participate in this case.
About The Author
Contact Henry Turner privately here. Or send an email with ATTN: Henry Turner as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.